Sandu Pharmaceuticals Ltd — Insider Trading, 21-03-2026: Insider Trading / SAST

SANDU PHARMACEUTICALS has announced the closure of its trading window for company securities. This restriction, effective from April 1, 2026, will remain in place until 48 hours after the financial results for the quarter and year ended March 31, 2026, are declared. This is a standard measure to prevent insider trading and applies to key personnel, promoters, and their immediate relatives. The company will announce the date of its Board Meeting to consider these financial results in due course. Shareholders should note that trading by insiders is restricted during this period.